[{"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0119-2025", "product_description": "Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b) 1000-count bottles (NDC 0378-1823-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "118,324 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8165919, Exp. Date Dec 2024; 8172050, Exp. Date Mar 2025; 8183251, Exp. Date  Sept 2025 b) 3185542, Exp. date  Dec 2024; 3192838, Exp. Date Mar 2025; 3208172, Exp. Date Sept 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Sacramento", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95714", "recalling_firm": "Boulla LLC", "address_1": "2108 N ST #7929", "address_2": "", "postal_code": "95816", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0085-2025", "product_description": "ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.", "recall_initiation_date": "20241104", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot #: YZM240406, Exp: 04/05/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0126-2025", "product_description": "Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "43,765 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot # a) 8180781, Exp. Date Aug 2025; b)3191628, Exp. Date Feb 2025; 3197139, Exp. Date Apr 2025; 3188976, Exp. Date Jan 2025; 3184929, Exp. Date Dec 2024; 3204909, Exp. Date Aug 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95511", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "N/A", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0025-2025", "product_description": "OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.", "product_quantity": "10845 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20241015", "center_classification_date": "20241024", "report_date": "20241030", "code_info": "Lot #ODS230001A, ODS230002A, Exp. 10/2025; ODS230003A, Exp. 11/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0015-2025", "product_description": "Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-024-58", "product_quantity": "1631 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000037046, exp. date 13-Oct-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95444", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0002-2025", "product_description": "Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45 gm Tube, NDC 68462-0455-47; c) 100 gm Tube, NDC 68462-0455-94, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.", "product_quantity": "11,568 tubes", "reason_for_recall": "Defective Container: Firm received complaints of broken tube at the seal.", "recall_initiation_date": "20240930", "center_classification_date": "20241002", "report_date": "20241009", "code_info": "Lot #s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026"}, {"status": "Ongoing", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075903"], "brand_name": ["LISINOPRIL"], "generic_name": ["LISINOPRIL"], "manufacturer_name": ["Legacy Pharmaceutical Packaging, LLC"], "product_ndc": ["68645-608", "68645-609", "68645-610", "68645-611", "68645-612", "68645-613"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISINOPRIL"], "rxcui": ["197884", "205326", "311353", "311354", "314076", "314077"], "spl_id": ["32ffefa5-4b45-4094-e063-6294a90a8255"], "spl_set_id": ["f5db9549-e179-3db6-e053-2995a90a1544"], "package_ndc": ["68645-609-90", "68645-610-90", "68645-611-90", "68645-608-90", "68645-612-90", "68645-613-90"], "original_packager_product_ndc": ["31722-176", "31722-177", "31722-178", "31722-172", "31722-179", "31722-180"], "upc": ["0368645610900", "0368645609904", "0368645613901", "0368645611907", "0368645608907", "0368645612904"], "unii": ["E7199S1YWR"]}, "product_type": "Drugs", "event_id": "95749", "recalling_firm": "Evaric Pharmaceuticals Inc.", "address_1": "155 Commerce Dr", "address_2": "N/A", "postal_code": "11788-3925", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0061-2025", "product_description": "Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC# 68645-610-90.", "product_quantity": "222, 600 bottles", "reason_for_recall": "Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.", "recall_initiation_date": "20241115", "center_classification_date": "20241120", "report_date": "20241127", "code_info": "Lot #: 241103, exp. date 05/31/2026"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95897", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0108-2025", "product_description": "Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-459-30", "product_quantity": "50,304 bottles", "reason_for_recall": "CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.", "recall_initiation_date": "20241127", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "Lot#: 44378, 44597, 45804, Exp 12/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Farnham", "state": "", "country": "United Kingdom", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95820", "recalling_firm": "Biocompatibles UK, Ltd.", "address_1": "Chapman House", "address_2": "Farnham Business Park; Weydon Lane", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0113-2025", "product_description": "Varithena (polidocanol injectable foam) Administration Pack, Contains: 3 silicone-free syringes, 2 compression pads, 1 Varithena Transfer Unit, 1 manometer tubing, Rx Only, Distributed by Biocompatibles Inc., a BTG International Group company. CN01114.3", "product_quantity": "432 administration packs", "reason_for_recall": "Defective Delivery System: incorrect silicone oil-free NormJect 10 mL Luer Lock Solo syringes packaged in the pack, instead of the required silicone oil-free NormJect 10 mL Luer Solo syringes (luer slip connection).", "recall_initiation_date": "20240815", "center_classification_date": "20241206", "termination_date": "20250221", "report_date": "20241218", "code_info": "Lot # 34067418, Exp. March 2026, 34067419, Exp. March 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95756", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0107-2025", "product_description": "Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99) bottles, Distributed by: Rising Pharmaceuticals, Inc., East Brunswick, NJ", "product_quantity": "233,003 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit", "recall_initiation_date": "20241119", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "a) 30s; DT6023059A, DT6023060A, DT6023065A, DT6023069A, DT6023070A, exp. date Jan-25, DT6023080A, exp. date Feb-25, DT6023093A, exp. date Mar-25, DTC24012A, exp. date Dec-25;  b) 90s; DT6023108A, exp. date Apr-25, DTC23201A, exp. date Aug-25;  c) 1000s;  DT6022160A,  DT6022165A,  DT6022162A,  DT6022164A,  DT6022163A,  DT6022171A,  DT6022169A,  DT6022170A,  DT6022173A, exp. date Nov-24, DT6023009A,  DT6023007A,  DT6023008A,  DT6023011A,  DT6023034B, exp. date Dec-24, DT6023067C, exp. date Jan-25, DT6023114A, exp. date Apr-25, DTC23243A, exp. date Oct-25, DTC24040A, exp. date Dec-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95849", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA, OH, PR", "recall_number": "D-0099-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories  NDC 68001-413-06", "product_quantity": "37,916 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit", "recall_initiation_date": "20241114", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lots: DT2023001A, DT2023009A, exp date Jan 31, 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217455"], "brand_name": ["REGADENOSON"], "generic_name": ["REGADENOSON"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-364"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["REGADENOSON"], "spl_id": ["9f2129bf-2527-42da-b07a-f20cac3246de"], "spl_set_id": ["a81d66a7-b714-439e-ad7b-c7caf9d6f3b8"], "package_ndc": ["36000-364-01"], "is_original_packager": [true], "upc": ["0336000364010"], "nui": ["N0000178375", "N0000175788"], "pharm_class_epc": ["Adenosine Receptor Agonist [EPC]"], "pharm_class_moa": ["Adenosine Receptor Agonists [MoA]"], "unii": ["2XLN4Y044H"]}, "product_type": "Drugs", "event_id": "95664", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0039-2025", "product_description": "Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015.  NDC: 36000-364-01", "product_quantity": "60,594 units", "reason_for_recall": "Labeling: Missing Label", "recall_initiation_date": "20241030", "center_classification_date": "20241106", "report_date": "20241113", "code_info": "Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211892"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-440", "16729-441", "16729-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["40aa0834-3fd8-c230-e063-6294a90a800d"], "spl_set_id": ["6bad4e06-c0a1-4123-83c2-67d3b081e8a9"], "package_ndc": ["16729-440-10", "16729-440-15", "16729-440-01", "16729-441-10", "16729-441-15", "16729-441-01", "16729-442-10", "16729-442-15", "16729-442-01"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95501", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0031-2025", "product_description": "Cinacalcet Tablets, 60 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-441-10, b) 90 Tablets per bottle, NDC: 16729-441-15, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.", "recall_initiation_date": "20241010", "center_classification_date": "20241031", "report_date": "20241106", "code_info": "a) Lot #:              Expiry Date: M2204481              02/2025 M2212389              08/2025 M2214271              09/2025 M2215970              10/2025 M2216458              10/2025  b) Lot #:             Expiry Date: M2212869           08/2025 M2216362           09/2025 M2215969           10/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Lilburn", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94893", "recalling_firm": "Guru Inc.", "address_1": "4370 Lawrenceville Hwy NW", "address_2": "# 2204", "postal_code": "30047-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Retail: South Carolina, North Carolina, Ohio;  Consumer level: Nationwide within USA", "recall_number": "D-0666-2024", "product_description": "Infla-650 Herbal Dietary Supplement, 700mg,  packaged in pouches containing 60 capsules, Distributed by: Guru Inc., 4370 Lawrenceville Hwy NW, P.O. Box 2204, Lilburn, GA 30047-1100, USA. Ph.: 872 216 1566, http://www.dalayurevda.com, Made in India, UPC: 042535355019", "product_quantity": "", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.", "recall_initiation_date": "20240626", "center_classification_date": "20240923", "report_date": "20241002", "code_info": "Batch # IN-032, Exp 11/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M013"], "brand_name": ["MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK"], "generic_name": ["DEXTROMETHORPHAN HBR, GUAIFENESIN, ACETAMINOPHEN, DOXYLAMINE SUCCINATE"], "manufacturer_name": ["Genexa Inc."], "product_ndc": ["69676-0079"], "product_type": ["HUMAN OTC DRUG"], "rxcui": ["2692302", "2692303", "2692304"], "spl_id": ["38f8afad-542e-ae0c-e063-6294a90a243f"], "spl_set_id": ["18835205-a9e3-15c2-e063-6394a90a8107"], "package_ndc": ["69676-0079-3", "69676-0077-9", "69676-0094-9", "8500157361"], "is_original_packager": [true], "upc": ["850015736155"]}, "product_type": "Drugs", "event_id": "95430", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "N/A", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two accounts that may have distributed the product further to the Retail Level.", "recall_number": "D-0033-2025", "product_description": "Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP  400mg),  packaged in 4 oz bottles further package in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code # 850015736155", "product_quantity": "72,648 bottles", "reason_for_recall": "Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.", "recall_initiation_date": "20240925", "center_classification_date": "20241101", "report_date": "20241113", "code_info": "Lot# 0104V, Exp 07/2025; 0106V, Exp 09/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208368"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-367", "43598-368", "43598-369"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["b6dbd55a-a71d-0cf8-2c73-7ebbfc032906"], "spl_set_id": ["0837aabc-e796-0e07-8958-71f1ff6e89bf"], "package_ndc": ["43598-367-30", "43598-367-05", "43598-368-30", "43598-368-05", "43598-369-30", "43598-369-05"], "is_original_packager": [true], "upc": ["0343598369303"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95500", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0027-2025", "product_description": "Cinacalcet Tablets, 60 mg, 30-count bottles, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India, NDC 43598-368-30.", "product_quantity": "35880 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241009", "center_classification_date": "20241028", "report_date": "20241106", "code_info": "Lot# T2200698, Exp 01/2025; T2201444, Exp 03/2025; T2202827, Exp 06/2025; T2300531, Exp 12/2025; T2301696, Exp 02/2026; T2304726, Exp 08/2026; T2400480, Exp 11/2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0023-2025", "product_description": "Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-079-56", "product_quantity": "1008 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000037436, exp. date 30-Oct-24 C274-000038893, exp. date 7-Jan-25", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA021859"], "brand_name": ["HYLENEX RECOMBINANT"], "generic_name": ["HYALURONIDASE"], "manufacturer_name": ["Antares Pharma, Inc."], "product_ndc": ["18657-117"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["HYALURONIDASE (HUMAN RECOMBINANT)"], "rxcui": ["630936", "630939"], "spl_id": ["37c02d08-e964-4065-ba96-69fe8eed5c2e"], "spl_set_id": ["3023cc56-ed4b-4e87-b3a1-81b20943f658"], "package_ndc": ["18657-117-01", "18657-117-02", "18657-117-04", "1000008319", "1000008206", "1000008205"], "is_original_packager": [true], "nui": ["N0000175531", "M0009499"], "pharm_class_epc": ["Endoglycosidase [EPC]"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "unii": ["743QUY4VD8"]}, "product_type": "Drugs", "event_id": "95830", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Virgina", "recall_number": "D-0116-2025", "product_description": "Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ  NDC 18657-117-04", "product_quantity": "5 cartons/20 units each carton", "reason_for_recall": "cGMP Deviations: Temperature excursion", "recall_initiation_date": "20240911", "center_classification_date": "20241210", "termination_date": "20250820", "report_date": "20241218", "code_info": "Serial # 100000831961 100000820688 100000820689 100000820515", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0092-2025", "product_description": "Compliance Dishwashing Liquid & Antibacterial Soap, PCMX 0.1%, Net Contents: 1 Gallon, 128 Ounces, 3.785 Liters,  Royal Corporation, 10232 Palm Drive, Santa Fe Springs, CA 90670", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-562", "68462-850", "68462-851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["52b392c0-72cb-4a91-8d27-5cacdb8a7778"], "spl_set_id": ["fb1606ea-1cff-46fd-b8e5-8135da76436c"], "package_ndc": ["68462-850-01", "68462-851-01", "68462-562-01"], "is_original_packager": [true], "upc": ["0368462562017", "0368462851012", "0368462850015"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0093-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-850-01.", "product_quantity": "34848 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #s: 17222544, Exp. Date 11/30/2024 ; 17230784, Exp Date 03/31/2025; 17231080, Exp. Date 04/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-553", "16714-554", "16714-555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["a11626b3-d7a9-43b0-85d4-38a582acd661"], "spl_set_id": ["e2511ffe-5821-4f64-a469-f8ef9618b1b5"], "package_ndc": ["16714-553-01", "16714-554-01", "16714-555-01"], "is_original_packager": [true], "upc": ["0316714554013", "0316714553016", "0316714555010"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0096-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-553-01.", "product_quantity": "5232 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #: 17222544, Exp 11/30/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0091-2025", "product_description": "Genuine Joe Antibacterial Lotion Soap , Chloroxylenol 0.1%, 1 GALLON (3.78L), Manufactured in the U.S.A. for S.P. Richards Co., Atlanta, GA 30339", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Ongoing", "city": "Shirley", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021135"], "brand_name": ["VENOFER"], "generic_name": ["IRON SUCROSE"], "manufacturer_name": ["American Regent, Inc."], "product_ndc": ["0517-2310", "0517-2325", "0517-2340"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["IRON SUCROSE"], "rxcui": ["1741261", "1741263", "1741267", "1741268", "1741270", "1741271"], "spl_id": ["1cb19ad9-7a23-43bd-ab28-955cd2fa3750"], "spl_set_id": ["626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a"], "package_ndc": ["0517-2325-01", "0517-2325-10", "0517-2340-01", "0517-2340-10", "0517-2340-25", "0517-2310-01", "0517-2310-05"], "is_original_packager": [true], "upc": ["0305172340016", "0305172340252"], "nui": ["M0011718", "N0000177913"], "pharm_class_cs": ["Iron [CS]"], "pharm_class_epc": ["Parenteral Iron Replacement [EPC]"], "unii": ["FZ7NYF5N8L"]}, "product_type": "Drugs", "event_id": "95711", "recalling_firm": "American Regent, Inc.", "address_1": "5 Ramsey Rd", "address_2": "", "postal_code": "11967-4701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0082-2025", "product_description": "Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, American Regent, Inc. Shirley, NY 11967, NDC: 0517-2340-01 (vial), NDC: 0517-2340-10 (10 x 5 mL/vial cartons), NDC: 0517-2340-25 (25 x 5 mL/vial cartons).", "product_quantity": "", "reason_for_recall": "Presence of Particulate Matter: Potential for glass delamination from the vials.", "recall_initiation_date": "20241111", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #s: 4205, Exp 05/31/2026; 24229, 24233, 24239, Exp 07/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-562", "68462-850", "68462-851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["52b392c0-72cb-4a91-8d27-5cacdb8a7778"], "spl_set_id": ["fb1606ea-1cff-46fd-b8e5-8135da76436c"], "package_ndc": ["68462-850-01", "68462-851-01", "68462-562-01"], "is_original_packager": [true], "upc": ["0368462562017", "0368462851012", "0368462850015"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0094-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 90 mg, Rx Only, 100 Capsules, Manufactured for : Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-851-01.", "product_quantity": "12,864 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #s 17222452, Exp. Date, 11/30/2024; 17230607, Exp. Date 02/28/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95715", "recalling_firm": "JR Watkins", "address_1": "400 Mill St Unit #D5", "address_2": "", "postal_code": "19007", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0075-2025", "product_description": "Cooling Menthol Extra Strength Pain Relief Patch, Menthol 7.5%, packaged in box of 5, Distributed by J.R. Watkins LLC, Oakland CA 94612 UPC 8 56294 00878 5,  NDC 72342-100-05", "product_quantity": "7,138 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241101", "center_classification_date": "20241127", "termination_date": "20250916", "report_date": "20241204", "code_info": "Lot # JC101, JC102 and JC103, exp. date Oct 31, 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA211746"], "brand_name": ["RYALTRIS"], "generic_name": ["OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE"], "manufacturer_name": ["HIKMA SPECIALTY USA INC."], "product_ndc": ["59467-700"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["MOMETASONE FUROATE MONOHYDRATE", "OLOPATADINE HYDROCHLORIDE"], "rxcui": ["2591806", "2591812"], "spl_id": ["b14c6f4f-8765-4436-8cc8-1e913f05a542"], "spl_set_id": ["382eac74-a7ce-4f42-ac0a-b253308f335f"], "package_ndc": ["59467-700-27", "59467-700-84"], "is_original_packager": [true], "upc": ["0359467700276"], "unii": ["MTW0WEG809", "2XG66W44KF"]}, "product_type": "Drugs", "event_id": "95389", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0006-2025", "product_description": "Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle, 29 g net fill weight, Distr. by Hikma Specialty USA Inc., Columbus, OH 43328, hikma, Glenmark Specialty SA. NDC 59467-700-27.", "product_quantity": "45,504 bottles", "reason_for_recall": "Defective Delivery System: The dip tube is clogged causing the spray not to work.", "recall_initiation_date": "20240924", "center_classification_date": "20241003", "report_date": "20241009", "code_info": "Lots 14230425, Exp Date, Nov-25; 14240024, Exp Date Dec-25; 14240029, Exp Date Dec-25; 14240076, Exp Date Jan-26; 14240082 Exp Date, Jan-26, 14240090, Exp Date Jan-26; and 14240100, Exp Date Jan-26"}, {"status": "Ongoing", "city": "Atlanta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94949", "recalling_firm": "Supercore Products Group Inc.", "address_1": "230 Peachtree St Nw", "address_2": "Ste 2200", "postal_code": "30303-1534", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide US (2014), Israel (2), Canada (12), Republic of Kosovo (1), Pakistan (1), Australia (3), Morocco (1), United Kingdom (1)", "recall_number": "D-0003-2025", "product_description": "Hard Steel Capsules packaged in 1 count blister packs in boxes of 10, 20 and 30, Manufactured in U.S.A.", "product_quantity": "729", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.", "recall_initiation_date": "20240712", "center_classification_date": "20241002", "report_date": "20241009", "code_info": "All lots"}, {"status": "Terminated", "city": "Bennet", "state": "NE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95503", "recalling_firm": "Staska Pharmaceuticals, Inc.", "address_1": "742 Evergreen Dr", "address_2": "N/A", "postal_code": "68317-2365", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0040-2025", "product_description": "Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317", "product_quantity": "4773 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of glass particulates.", "recall_initiation_date": "20240930", "center_classification_date": "20241107", "termination_date": "20250805", "report_date": "20241113", "code_info": "Lot #SP2400058, Exp 12/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Vaudreuil-Dorion", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["M020"], "brand_name": ["SHEET SPF 30 MINERAL"], "generic_name": ["TITANIUM DIOXIDE, ZINC OXIDE"], "manufacturer_name": ["Vivier Pharma Inc."], "product_ndc": ["67226-2232"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["TITANIUM DIOXIDE", "ZINC OXIDE"], "spl_id": ["1159e6f6-423b-51ac-e063-6394a90ab0a4"], "spl_set_id": ["bbb5b87c-d641-3ba2-e053-2a95a90a0f70"], "package_ndc": ["67226-2232-6"], "is_original_packager": [true], "upc": ["0696163800337"], "unii": ["15FIX9V2JP", "SOI2LOH54Z"]}, "product_type": "Drugs", "event_id": "95339", "recalling_firm": "Vivier Pharma, Inc.", "address_1": "288 Adrien-Patenaude St", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0662-2024", "product_description": "Vivier Sheer SPF 30 Mineral With Antioxidants (titanium dioxide 10% and zinc oxide 8%) packaged in 60 ml/2 fl oz, Vivier Canada Inc. / Mfd. for Vivier Pharma, Vaudereull-Dorion OC Canada, J7V 5V5, Champlain, NY USA 12919, Made in Canada, NDC 67226-2232-6. SKU 10-160-ZZ-80059-R", "product_quantity": "3476 units", "reason_for_recall": "Microbial Contamination of Non-Sterile Product", "recall_initiation_date": "20240903", "center_classification_date": "20240920", "report_date": "20241002", "code_info": "Lot #: 91771, Exp. Date 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M013"], "brand_name": ["MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK"], "generic_name": ["DEXTROMETHORPHAN HBR, GUAIFENESIN, ACETAMINOPHEN, DOXYLAMINE SUCCINATE"], "manufacturer_name": ["Genexa Inc."], "product_ndc": ["69676-0079"], "product_type": ["HUMAN OTC DRUG"], "rxcui": ["2692302", "2692303", "2692304"], "spl_id": ["38f8afad-542e-ae0c-e063-6294a90a243f"], "spl_set_id": ["18835205-a9e3-15c2-e063-6394a90a8107"], "package_ndc": ["69676-0079-3", "69676-0077-9", "69676-0094-9", "8500157360"], "is_original_packager": [true], "upc": ["850015736018"]}, "product_type": "Drugs", "event_id": "95430", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "N/A", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two accounts that may have distributed the product further to the Retail Level.", "recall_number": "D-0034-2025", "product_description": "Kids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg), packaged in 4 oz bottles further packaged in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code# 850015736018", "product_quantity": "105,048 bottles", "reason_for_recall": "Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.", "recall_initiation_date": "20240925", "center_classification_date": "20241101", "report_date": "20241113", "code_info": "Lot#: 0813V, Exp 06/2025; 0103V, Exp 03/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "95921", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one Us Distributor in NJ.", "recall_number": "D-0114-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.25%, Sterile, 15mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-513-15.", "product_quantity": "5184 bottles", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20241205", "center_classification_date": "20241206", "report_date": "20241218", "code_info": "Lot #: 083I006, Exp 08/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0063-2025", "product_description": "ABSORBINE jr ULTRA STRENGTH PAIN PATCH, Menthol 6.5%, 1 patch per box, Distributed By: Absorbine Jr. LLC, Chattanooga, TN 37402 UPC 8 89476 41318 3, UPC 8 89476 41336 7", "product_quantity": "4,968,000 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 89476 41318 3, UPC 8 89476 41336 7", "more_code_info": ""}, {"status": "Ongoing", "city": "Fort Mill", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95587", "recalling_firm": "Trinity Gold Nutrition", "address_1": "201 Tom Hall St", "address_2": "STE 2107", "postal_code": "29715-2313", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States; additionally Canada, England, and Australia.", "recall_number": "D-0042-2025", "product_description": "Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPC 802992001009", "product_quantity": "150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.", "recall_initiation_date": "20241106", "center_classification_date": "20241112", "report_date": "20241120", "code_info": "Lot #: IN-030, Exp. Date: NOV 2027"}, {"status": "Ongoing", "city": "Mumbai", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA202862"], "brand_name": ["OLANZAPINE"], "generic_name": ["OLANZAPINE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-067", "33342-068", "33342-069", "33342-070", "33342-071", "33342-072"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLANZAPINE"], "rxcui": ["200034", "283639", "312077", "312078", "312079", "314154"], "spl_id": ["3cb20bd0-3dd5-4742-b2d6-bfbeb8878d31"], "spl_set_id": ["8e095987-bdea-42f2-9550-c7155cf07d30"], "package_ndc": ["33342-067-07", "33342-067-44", "33342-067-12", "33342-067-11", "33342-068-07", "33342-068-44", "33342-068-12", "33342-068-11", "33342-069-07", "33342-069-44", "33342-069-12", "33342-069-11", "33342-070-07", "33342-070-15", "33342-070-12", "33342-070-44", "33342-070-11", "33342-071-07", "33342-071-15", "33342-071-12", "33342-071-44", "33342-071-11", "33342-072-07", "33342-072-15", "33342-072-12", "33342-072-44", "33342-072-11"], "is_original_packager": [true], "upc": ["0333342067074", "0333342070074", "0333342069078", "0333342072078", "0333342071071", "0333342068071"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["N7U69T4SZR"]}, "product_type": "Drugs", "event_id": "95838", "recalling_firm": "Macleods Pharmaceuticals Ltd", "address_1": "304 Atlanta Arcade", "address_2": "Church Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0154-2025", "product_description": "Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured for: Macleods Pharma USA Inc. Princeton, NJ,08540: Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-067-07.", "product_quantity": "15,744 30-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20241125", "center_classification_date": "20241219", "report_date": "20241225", "code_info": "Lot# BOB12318A Exp 07/31/2027", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0071-2025", "product_description": "CHEEKY BONSAI PAIN RELIEF PATCHES, Menthol 10%, 4 patches per box, Distributed by Cheeky Bonsai, San Francisco, CA UPC 8 60006 57564 9", "product_quantity": "17,928 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 60006 57564 9", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206125"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-831", "65862-832", "65862-833"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["5aadf0b6-2c49-48d4-8d22-2fbf99dbf4e6"], "spl_set_id": ["42e99112-c402-4662-877f-9e3a84dff9f2"], "package_ndc": ["65862-831-30", "65862-831-90", "65862-831-01", "65862-831-05", "65862-832-30", "65862-832-90", "65862-832-01", "65862-832-05", "65862-833-30", "65862-833-90", "65862-833-01", "65862-833-05"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95730", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0079-2025", "product_description": "Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-833-30), b) 500-count HDPE bottle (NDC 65862-833-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.  90 mg - 30 Tablets - NDC 65862-833-30 90 mg - 500 Tablets - NDC 65862-833-05", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241107", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #: a) CFSC23001A, CFSC23001B, Exp 03/31/2025; b) P2300195, Exp 12/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95304", "recalling_firm": "Empower Pharmacy", "address_1": "5980 W Sam Houston Pkwy N Ste 300", "address_2": "", "postal_code": "77041-5254", "voluntary_mandated": "", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0663-2024", "product_description": "Pyridoxine HCL (B6) Injection Solution, 100mg/mL, 30 mL Sterile Multiple-Dose Vial, For IM or IV use only, RX Only, Compounded by: Empower Pharmacy 5980 W Sam Houston Pkwy N Ste 300, Houston, TX 77041 NDC 72627-2424-1.", "product_quantity": "450", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240905", "center_classification_date": "20240920", "termination_date": "20250214", "report_date": "20241002", "code_info": "Product lot number: 609763 Beyond Use Date: 04/18/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211892"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-440", "16729-441", "16729-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["40aa0834-3fd8-c230-e063-6294a90a800d"], "spl_set_id": ["6bad4e06-c0a1-4123-83c2-67d3b081e8a9"], "package_ndc": ["16729-440-10", "16729-440-15", "16729-440-01", "16729-441-10", "16729-441-15", "16729-441-01", "16729-442-10", "16729-442-15", "16729-442-01"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95501", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0030-2025", "product_description": "Cinacalcet Tablets 30 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-440-10, b) 90 Tablets per bottle, NDC: 16729-440-15, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.", "recall_initiation_date": "20241010", "center_classification_date": "20241031", "report_date": "20241106", "code_info": "a) Lot #:             Expiry Date: M2118190        11/2024 M2201091        11/2024 M2206241             11/2024 M2206451             04/2025 M2208674             06/2025 M2213850             08/2025 M2215221             09/2025 M2216236             11/2025 M2217098             11/2025 M2300664             11/2025  b) Lot #:           Expiry Date: M2210808            06/2025 M2212212            08/2025 M2214435            09/2025 M2217097            11/2025 M2301921            01/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0018-2025", "product_description": "Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-014-58", "product_quantity": "1082 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038004, exp. date 27-Nov-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0057-2025", "product_description": "Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-108-01", "product_quantity": "3139 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 24A0050, exp. date 04/25/2026; 24A0055, exp. date 05/09/2026; 24A0059, exp. date 05/16/2026; 24A0060, exp. date 05/20/2026; 24A0071, exp. date 06/24/2026; 24A0072, exp. date 06/26/2026"}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95647", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "N/A", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0046-2025", "product_description": "Perio Maintenance Rinse 0.63% Stannous Fluoride Concentrated Solution, Rx Only, Net Wt. 10 oz. (283.5 g) pumps, Mint flavor, Manufactured by: Keystone Industries, 480 S. Democrat Rd., Gibbstown, NJ 08027, NDC 68400-202-10", "product_quantity": "787 pumps", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20241017", "center_classification_date": "20241114", "report_date": "20241120", "code_info": "Lot #: PVC-003015, Exp. Date Sep-21-2025; PVC-003061, Exp. Date Apr-30-2026"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95756", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0106-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90) and c) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ", "product_quantity": "122,925 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit", "recall_initiation_date": "20241119", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "a) 30s; DT3023019A, exp. date Jan-25 DT3023050A, exp. date Apr-25;  b) 90s; DT3023022A, exp. date Jan-25;  c) 1000s; DT3022108A, DT3022107A, DT3022106A, DT3022111A, DT3022109A, exp. date Nov-24, DT3023001A, DT3023003A, exp. date Dec-24, DT3023024A, DT3023020B, exp. date Jan-25 DT3023027A, DT3023028A, exp. date Feb-25, DT3023034A, exp. date Mar-25, DT3023049A, exp. date Apr-25, DT3023095A, exp. date Jul-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0087-2025", "product_description": "MAXIM Assure Antibacterial,  Chloroxylenol 0.1%, Net Contents: One U.S. Gallon (3.78 L), For Industrial and Institutional Use Only, MIDLAB 140 Private Brand Way, Athens, TN 37303", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040074"], "brand_name": ["PROPARACAINE HYDROCHLORIDE"], "generic_name": ["PROPARACAINE HYDROCHLORIDE"], "manufacturer_name": ["Bausch & Lomb Incorporated"], "product_ndc": ["24208-730"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["PROPARACAINE HYDROCHLORIDE"], "rxcui": ["1191013"], "spl_id": ["46f24726-30f8-471b-b0be-b7da62d88bfc"], "spl_set_id": ["b699f838-8b69-4bac-953b-ea8822ec19fc"], "package_ndc": ["24208-730-06"], "is_original_packager": [true], "unii": ["U96OL57GOY"]}, "product_type": "Drugs", "event_id": "95333", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two medical facilities in MD and VA.", "recall_number": "D-0661-2024", "product_description": "Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24208-730-06", "product_quantity": "27 bottles", "reason_for_recall": "Temperature abuse: Products exposed to improper temperature above drug label specifications.", "recall_initiation_date": "20240911", "center_classification_date": "20240920", "termination_date": "20250129", "report_date": "20241002", "code_info": "Lot # 476261, 479751, 479741, Exp 3/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0125-2025", "product_description": "Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count bottles (NDC 0378-1805-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "63,077 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8177078, Exp. Date May 2025; 8168596, Exp. Date Jan 2025 b) 3199313, Exp. Date May 2025; 3194118, Exp. Date Mar 2025; 3186238, Exp. Date Dec 2024; 3209590, Exp. Date Sep 2025; 3199317, Exp. Date May 2025; 3188733, Exp. Date Jan 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95611", "recalling_firm": "Cipla USA, Inc.", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0044-2025", "product_description": "Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90", "product_quantity": "N/A", "reason_for_recall": "Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.", "recall_initiation_date": "20241023", "center_classification_date": "20241112", "report_date": "20241120", "code_info": "Lot# NB240873, Exp 03/31/2026"}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0056-2025", "product_description": "Vitamin D3, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-104-01", "product_quantity": "7488 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 24A0052, exp. date 05/01/2026; 24A0057, exp. date 05/13/2026; 24A0066, exp. date 05/31/2026; 24A0067, exp. date 06/04/2026; 24A0068, exp. date 06/17/2026; 24A0069, exp. date 06/19/2026 24A0075, exp. date 07/08/2026 24A0078, exp. date 07/12/2026"}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0143-2025", "product_description": "Burkhart, Topical Anesthetic Gel, Benzocaine 20%, Gluten Free, 1 FL. OZ (30 ml), Manufactured for Burkhart Dental Supply, Tacoma, Washington 98409.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-29119", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0064-2025", "product_description": "ABSORBINE JR PAIN RELIEVING KNEE PATCH, Camphor 7%, Menthol 7%, packaged in a) 1 patch (UPC 8 89476 41251 3) and b) 6 patches (UPC 8 89476 41306 0), Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402", "product_quantity": "946,080 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "a) UPC 8 89476 41251 3 b) UPC 8 89476 41306 0", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["PATTERSON DENTAL TOPICAL ANESTHETIC"], "generic_name": ["BENZOCAINE"], "manufacturer_name": ["Patterson Dental"], "product_ndc": ["50227-1002"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["BENZOCAINE"], "rxcui": ["238910"], "spl_id": ["2b3af1da-d771-a62c-e063-6394a90abfcc"], "spl_set_id": ["a948c5a7-d431-4f46-bb59-8974924e6320"], "package_ndc": ["50227-1002-3"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5"]}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0141-2025", "product_description": "Patterson Dental, Patterson Topical Anesthetic Gel, Benzocaiine, 1 oz. (30 ml), Manufactured for (Fabrique pour): Patterson Dental Supply, Inc. 1031 Mendota Heights Road, Saint Paul, MN 55120, NDC 50227-1002-3.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-27119", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0123-2025", "product_description": "Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count bottles (NDC 0378-1800-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "34,845 bottes", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8181875, Exp. Date Aug 2025; 8174497, Exp. Date April 2025 b) 3209099, Exp. Date Sep 2025; 3206534, Exp. Date Aug 2025; 3196137, Exp. Date April 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0014-2025", "product_description": "Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-002-58", "product_quantity": "1313 bags", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot# C274-000039006, exp. date 19-Jan-25", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95756", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0105-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ  NDC 57237-017-60", "product_quantity": "209,376 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit", "recall_initiation_date": "20241119", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "a) Lot # DT2022023A, DT2022024A, DT2022025A, DT2022026A, DT2022027A, exp. date Nov-24 DT2023001B, DT2023004A, DT2023005A, DT2023006A, exp. date Jan-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208368"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-367", "43598-368", "43598-369"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["b6dbd55a-a71d-0cf8-2c73-7ebbfc032906"], "spl_set_id": ["0837aabc-e796-0e07-8958-71f1ff6e89bf"], "package_ndc": ["43598-367-30", "43598-367-05", "43598-368-30", "43598-368-05", "43598-369-30", "43598-369-05"], "is_original_packager": [true], "upc": ["0343598369303"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95500", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0026-2025", "product_description": "Cinacalcet Tablets, 30 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India, NDC 43598-367-30.", "product_quantity": "285126 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241009", "center_classification_date": "20241028", "report_date": "20241106", "code_info": "Lot# T2200120, T2200121, T2200119, T2200116, T2200118, T2200117, Exp 11/2024; T2200695, T2200694, T2200696, T2200697, Exp 01/2025; T2201426, T2201428, T2201432, T2201427, T2201430, T2201429, T2201431, Exp 03/2025; T2202743, T2202742, T2202741, & T2202740, Exp 06/2025; T2203081, T2203079, T2203080, T2203082, T2203083 & T2203084, Exp 07/2025; T2300770, T2300771, T2300769, T2300766, T2300767 & T2300768, Exp 12/2025  Lots T2301663, T2301665, T2301662, T2301664, T2301667, T2301661, T2301666, T2301660, T2301658 & T2301659, Exp Date 02/2026  Lots T2304704, T2304703, T2304705, T2304706, Exp Date 08/2026  Lots T2400468, T2400469, T2400473 & T2400474 Exp Date 11/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Rosemead", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95391", "recalling_firm": "123Herbals", "address_1": "7214 Berne St", "address_2": "", "postal_code": "91770-3844", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed via Amazon and 123Herbals.com website", "recall_number": "D-0008-2025", "product_description": "Vail-Bon Jie Yang Wan capsules, 30-count bottle, Vall Boon Medical Factory Sdn. Bhd., No 1, Lorong Mengkudu, Taman Mengkudu, 14100 Juru, Malaysia.", "product_quantity": "unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared dexamethasone and chlorpheniramine.", "recall_initiation_date": "20240918", "center_classification_date": "20241010", "report_date": "20241016", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Ongoing", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95332", "recalling_firm": "AbbVie Inc.", "address_1": "1 N Waukegan Rd", "address_2": "", "postal_code": "60064-1802", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)", "recall_number": "D-0665-2024", "product_description": "Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940,   UPC code: 300230312042", "product_quantity": "763,426 tubes", "reason_for_recall": "Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.", "recall_initiation_date": "20240916", "center_classification_date": "20240923", "report_date": "20241002", "code_info": "Lot: 387489, Exp. Oct 24; 387490, Exp. Jun 25; 390422, Exp. Nov 24; 390424, Exp. Oct 24; 391692, Exp. Jun 25; 391893, Exp. Nov 25; 394822, Exp. Feb 26; 395991, Exp. Mar 26; 397905, 397973, 397974, Exp May 26; 399019, 399254, Exp. Jun 26; 399922, Exp. Jul 26; 408738, Exp. Mar 27; T3911, Exp. Sep 24; T4015, T4031, T4032, T4033, T4108, Exp. Oct 24.", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0017-2025", "product_description": "Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-029-58", "product_quantity": "1378 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038499, exp. date 21-Dec-24", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["HEALTHWISE MENSTRUAL PAIN RELIEF PATCH"], "generic_name": ["MENTHOL"], "manufacturer_name": ["Veridian Healthcare"], "product_ndc": ["71101-947"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["MENTHOL, UNSPECIFIED FORM"], "rxcui": ["2621715"], "spl_id": ["29922bcf-4924-bc88-e063-6294a90a3002"], "spl_set_id": ["ee62e44e-a09f-2e58-e053-2a95a90abe04"], "package_ndc": ["71101-947-10"], "is_original_packager": [true], "unii": ["L7T10EIP3A"], "upc": ["845717010726"]}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0067-2025", "product_description": "HealthWise PERIOD PATCH Menstrual Pain Relief, Menthol 10%, 10 patches per box, Manufactured for Veridian Healthcare, LLC, Gurnee, IL  60031 NDC 71101-947-10, UPC 8 45717 01072 6", "product_quantity": "10,368 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 45717 01072 6", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213803"], "brand_name": ["SUNITINIB MALATE"], "generic_name": ["SUNITINIB MALATE"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-901", "42291-902", "42291-903", "42291-904"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUNITINIB MALATE"], "rxcui": ["616279", "616285", "616289", "1541890"], "spl_id": ["0772f635-a03d-3c10-e063-6294a90a67ad"], "spl_set_id": ["0772eb61-ca42-39de-e063-6294a90a6632"], "package_ndc": ["42291-901-28", "42291-902-28", "42291-903-28", "42291-904-28"], "original_packager_product_ndc": ["0093-8199", "0093-8224", "0093-8229", "0093-8231"], "unii": ["LVX8N1UT73"]}, "product_type": "Drugs", "event_id": "95596", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0104-2025", "product_description": "Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478.  NDC 42291-902-28", "product_quantity": "20 bottles", "reason_for_recall": "Labeling: Label Mix-Up", "recall_initiation_date": "20241018", "center_classification_date": "20241204", "report_date": "20241211", "code_info": "Lot #: 100049501, Exp. Date 07/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["REGENER-EYES"], "generic_name": ["REGENER-EYES"], "manufacturer_name": ["Regenerative Processing Plant, LLC"], "product_ndc": ["82305-003"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["GLYCERIN"], "rxcui": ["2540675", "2609932"], "spl_id": ["30cb2afc-827d-5e43-e063-6294a90a50e3"], "spl_set_id": ["e689001a-3640-1d45-e053-2995a90a4032"], "package_ndc": ["82305-003-01", "82305-003-02"], "is_original_packager": [true], "nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["PDC6A3C0OX"]}, "product_type": "Drugs", "event_id": "95912", "recalling_firm": "Regenerative Processing Plant, LLC", "address_1": "34176 Us Highway 19 N", "address_2": "", "postal_code": "34684-2144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0153-2025", "product_description": "PROFESSIONAL Regener-Eyes, Ophthalmic Solution (glycerin 0.5%) , 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL; Manufactured by: Regenerative Processing Plant, LLC, 34176 US HWY 19N, FL, NDC 82305-003-01", "product_quantity": "59275", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20241210", "center_classification_date": "20241217", "termination_date": "20250627", "report_date": "20241225", "code_info": "Lot #: P120522A, Exp. Date 12/5/2025, P120522B, Exp. Date 12/5/2024; P120822A, Exp. Date 12/8/2024; P1208228, Exp. Date 12/8/2024; P121222A, P1212228, Exp. Date 12/12/2024; P121922A, P121922B, Exp. Date 12/19/2024; P122222A, Exp. Date  12/22/2024; P122622A, P122622B, Exp. Date 12/26/2024; P010223A, Exp. Date 1/2/2025; P010423PV1, Exp. Date 1/4/2025; P010523A, P010523B, Exp. Date 1/5/2025; P010923A, Exp. Date 1/9/2025; P011123PV2, Exp. Date 1/11/2025; P011223A, P011223B, Exp. Date 1/12/2025; P011623A, Exp. Date 1/16/2025; P011823PV3, Exp. Date 1/18/2025; P011923A, P011923B, Exp. Date 1/19/2025; P012323A, P012323B, Exp. Date 1/23/2025; P012623A, Exp. Date 1/26/2025; P013023A, Exp. Date 1/30/2025; P020123A, Exp. Date 2/1 /2025; P020723A, Exp. Date 2/7/2025; P021423, Exp. Date 2/14/2025, P021623A, Exp. Date 2/16/2025; P022023A, Exp. Date 2/20/2025; P022223A, Exp. Date 2/22/2025; P022823A, Exp. Date 2/28/2025; P030123A, Exp. Date 3/1/2025; P050423A, Exp. Date 5/4/2025, P051823A, Exp. Date 5/18/2025, P052523A, Exp. Date 5/25/2025", "more_code_info": ""}, {"status": "Completed", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090480"], "brand_name": ["MUPIROCIN"], "generic_name": ["MUPIROCIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-180"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["MUPIROCIN"], "rxcui": ["106346"], "spl_id": ["1560b587-27d8-49cd-9b43-21cc6c30afc1"], "spl_set_id": ["ff7428fb-9ce9-4743-b58c-01a05424a57a"], "package_ndc": ["68462-180-22"], "is_original_packager": [true], "nui": ["N0000175515", "N0000175516"], "pharm_class_epc": ["RNA Synthetase Inhibitor Antibacterial [EPC]"], "pharm_class_moa": ["RNA Synthetase Inhibitors [MoA]"], "unii": ["D0GX863OA5"]}, "product_type": "Drugs", "event_id": "95279", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States.", "recall_number": "D-0660-2024", "product_description": "Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.", "product_quantity": "2,031,480 ointments", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240830", "center_classification_date": "20240920", "report_date": "20241002", "code_info": "Lot #: 19223615, 19223537, 19223544,19223568, 19223593,19223641, Exp. Date 08/2024;  19224055,19224281, 19224307, 19224321,  19224341, 19224467, Exp. Date 09/2024;  19224525, 19224542, 19224560,19224580, Exp. Date 10/2024; 19224990, 19224998, 19225014, 19225033, 19225293, 19225304, 19225320, 19225349, 19225367, 19225379,  19225401, Exp. Date 11/2024; 19230115, 19230123, 19230132, 19230137, 19230167,  19230170, Exp. Date 12/2024; 19230572, 19230607, 19230614, 19230628, 19230631, Exp. Date 1/2025; 19230874, 19230925,19230941, 19230957, 19230976,19231232, 19231238,  19231282,19231285, Exp. Date 02/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95588", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0037-2025", "product_description": "Morphine Sulfate Extended-Release Tablets 30 mg,  100-count bottles, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-186-01.", "product_quantity": "532 100-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specification", "recall_initiation_date": "20241022", "center_classification_date": "20241104", "report_date": "20241113", "code_info": "Lot# FG13996, Exp 09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Lexington", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["LICEOUT"], "generic_name": ["PIPERONYL BUTOXIDE AND PYRETHRUM EXTRACT"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-124"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["PIPERONYL BUTOXIDE", "PYRETHRUM EXTRACT"], "rxcui": ["283217", "2599624"], "spl_id": ["261c741f-1376-8ce1-e063-6394a90a92a0"], "spl_set_id": ["37805f32-b71f-4f8a-a4a3-2d26a8cbf564"], "package_ndc": ["53247-124-01", "53247-124-02"], "is_original_packager": [true], "unii": ["LWK91TU9AH", "ZUM06L90GV"]}, "product_type": "Drugs", "event_id": "95823", "recalling_firm": "Neogen Corporation", "address_1": "1847 Mercer Rd Ste A", "address_2": "", "postal_code": "40511-1001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.", "recall_number": "D-0074-2025", "product_description": "LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526.  NDC: 53247-124-02", "product_quantity": "8,328 jugs", "reason_for_recall": "CGMP violations.", "recall_initiation_date": "20241008", "center_classification_date": "20241127", "report_date": "20241204", "code_info": "Lot, expiry:  LO09530, exp 11/3/2024; LO13412, exp 12/7/2024; LO10263, exp 1/26/2025; LO11303, exp 5/10/2025; LO12153, exp 8/3/2025; LO12483, exp 9/5/2025; LO13183, exp 11/14/2025; LO106024, exp 2/29/2026; LO108624, exp 3/26/2026; LO110224, exp 4/11/2026", "more_code_info": ""}]